Cases & Deals

Celgene announces $2.9 billion acquisition of Pharmion

Clients Celgene Corporation

Jones Day advised Celgene Corporation in its $2.9 billion acquisition of Pharmion. In the merger, Pharmion shareholders received in exchange for their stock, Celgene stock and cash.

We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.